A Case-Control Association Study of RANTES (-28C>G) Polymorphism as a Risk Factor for Parkinson’s Disease in Isparta, Turkey
Background. Recent studies have revealed that inflammatory processes are involved in the pathogenesis of Parkinson’s disease (PD). Multiple lines of evidence have suggested that chemokines and their receptors are involved in several neurodegenerative disorders. We have examined whether genetic polym...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.1155/2016/5042604 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832552043439456256 |
---|---|
author | Nilufer Sahin-Calapoglu Serpil Demirci Mustafa Calapoglu Baris Yasar |
author_facet | Nilufer Sahin-Calapoglu Serpil Demirci Mustafa Calapoglu Baris Yasar |
author_sort | Nilufer Sahin-Calapoglu |
collection | DOAJ |
description | Background. Recent studies have revealed that inflammatory processes are involved in the pathogenesis of Parkinson’s disease (PD). Multiple lines of evidence have suggested that chemokines and their receptors are involved in several neurodegenerative disorders. We have examined whether genetic polymorphisms at the genes encoding chemokines IL-8 (-251A>T), MCP-1 (-2518A/G), and RANTES (-28C>G) and chemokine receptors CCR2 (V64I) and CCR5 (-Δ32) were associated with sporadic PD risk in Isparta, Turkey. Method. The pilot case-control association study included 30 PD patients and 60 control subjects, who were all genotyped with PCR-RFLP for the five polymorphisms. Their genotype and haplotype frequencies were compared statistically. Results. One SNP (-28C>G) in RANTES revealed a significant association with PD (P (allele) < 0.0001, p-trend = 0.0007). The risk allele (G) in the homozygous and dominant models (OR = 17.29 and 32.10, 95% CI = 0.86–347.24 and 1.74–591.937, resp.) suggests additional PD risk. The haplotype TGCAN from the IL-8 (-251A>T), MCP-1 (-2518A>G), RANTES (-28C>G), CCR-2 (V64I), and CCR-5 (-Δ32) has protective effect (OR = 0.08 [CI = 0.01–0.63], p=0.019). Conclusions. Our data are the first indication of the role of RANTES (-28C>G) in PD risk. |
format | Article |
id | doaj-art-baf9d2fc26314cb08b44046269b9e641 |
institution | Kabale University |
issn | 2090-8083 2042-0080 |
language | English |
publishDate | 2016-01-01 |
publisher | Wiley |
record_format | Article |
series | Parkinson's Disease |
spelling | doaj-art-baf9d2fc26314cb08b44046269b9e6412025-02-03T05:59:43ZengWileyParkinson's Disease2090-80832042-00802016-01-01201610.1155/2016/50426045042604A Case-Control Association Study of RANTES (-28C>G) Polymorphism as a Risk Factor for Parkinson’s Disease in Isparta, TurkeyNilufer Sahin-Calapoglu0Serpil Demirci1Mustafa Calapoglu2Baris Yasar3Department of Medical Biology, Faculty of Medicine, Süleyman Demirel University, Isparta, TurkeyDepartment of Neurology, Faculty of Medicine, Süleyman Demirel University, Isparta, TurkeyDepartment of Biochemistry, Faculty of Science, Süleyman Demirel University, Isparta, TurkeyDepartment of Medical Biology, Faculty of Medicine, Süleyman Demirel University, Isparta, TurkeyBackground. Recent studies have revealed that inflammatory processes are involved in the pathogenesis of Parkinson’s disease (PD). Multiple lines of evidence have suggested that chemokines and their receptors are involved in several neurodegenerative disorders. We have examined whether genetic polymorphisms at the genes encoding chemokines IL-8 (-251A>T), MCP-1 (-2518A/G), and RANTES (-28C>G) and chemokine receptors CCR2 (V64I) and CCR5 (-Δ32) were associated with sporadic PD risk in Isparta, Turkey. Method. The pilot case-control association study included 30 PD patients and 60 control subjects, who were all genotyped with PCR-RFLP for the five polymorphisms. Their genotype and haplotype frequencies were compared statistically. Results. One SNP (-28C>G) in RANTES revealed a significant association with PD (P (allele) < 0.0001, p-trend = 0.0007). The risk allele (G) in the homozygous and dominant models (OR = 17.29 and 32.10, 95% CI = 0.86–347.24 and 1.74–591.937, resp.) suggests additional PD risk. The haplotype TGCAN from the IL-8 (-251A>T), MCP-1 (-2518A>G), RANTES (-28C>G), CCR-2 (V64I), and CCR-5 (-Δ32) has protective effect (OR = 0.08 [CI = 0.01–0.63], p=0.019). Conclusions. Our data are the first indication of the role of RANTES (-28C>G) in PD risk.http://dx.doi.org/10.1155/2016/5042604 |
spellingShingle | Nilufer Sahin-Calapoglu Serpil Demirci Mustafa Calapoglu Baris Yasar A Case-Control Association Study of RANTES (-28C>G) Polymorphism as a Risk Factor for Parkinson’s Disease in Isparta, Turkey Parkinson's Disease |
title | A Case-Control Association Study of RANTES (-28C>G) Polymorphism as a Risk Factor for Parkinson’s Disease in Isparta, Turkey |
title_full | A Case-Control Association Study of RANTES (-28C>G) Polymorphism as a Risk Factor for Parkinson’s Disease in Isparta, Turkey |
title_fullStr | A Case-Control Association Study of RANTES (-28C>G) Polymorphism as a Risk Factor for Parkinson’s Disease in Isparta, Turkey |
title_full_unstemmed | A Case-Control Association Study of RANTES (-28C>G) Polymorphism as a Risk Factor for Parkinson’s Disease in Isparta, Turkey |
title_short | A Case-Control Association Study of RANTES (-28C>G) Polymorphism as a Risk Factor for Parkinson’s Disease in Isparta, Turkey |
title_sort | case control association study of rantes 28c g polymorphism as a risk factor for parkinson s disease in isparta turkey |
url | http://dx.doi.org/10.1155/2016/5042604 |
work_keys_str_mv | AT nilufersahincalapoglu acasecontrolassociationstudyofrantes28cgpolymorphismasariskfactorforparkinsonsdiseaseinispartaturkey AT serpildemirci acasecontrolassociationstudyofrantes28cgpolymorphismasariskfactorforparkinsonsdiseaseinispartaturkey AT mustafacalapoglu acasecontrolassociationstudyofrantes28cgpolymorphismasariskfactorforparkinsonsdiseaseinispartaturkey AT barisyasar acasecontrolassociationstudyofrantes28cgpolymorphismasariskfactorforparkinsonsdiseaseinispartaturkey AT nilufersahincalapoglu casecontrolassociationstudyofrantes28cgpolymorphismasariskfactorforparkinsonsdiseaseinispartaturkey AT serpildemirci casecontrolassociationstudyofrantes28cgpolymorphismasariskfactorforparkinsonsdiseaseinispartaturkey AT mustafacalapoglu casecontrolassociationstudyofrantes28cgpolymorphismasariskfactorforparkinsonsdiseaseinispartaturkey AT barisyasar casecontrolassociationstudyofrantes28cgpolymorphismasariskfactorforparkinsonsdiseaseinispartaturkey |